CCL4 and metabolic dysfunction-associated steatohepatitis: Thus, building upon our previous research, this study will establish a NASH mouse model using a Western diet combined with intraperitoneal injections of trace amounts of CCL4, and employ PCP intervention to explore how PCP ameliorates NASH by modulating gut microbiota and hepatic metabolites [17].